BRISTOL-MYERS SQUIBB COMPANY |
Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
| 42,6 USD | -1,74 % |
|
-4,82 % | -17,06 % |
| 14:34 | Bristol-Myers Squibb dice que la FDA estadounidense reasigna la fecha de acción del nivolumab subcutáneo | MT |
| 16/05 | EE.UU. - Valores a seguir en Wall Street (actualizado) |  |
Publs. oficiales
| Slide show Q1 | CO | |
| 1st quarter results | CO | |
| Annual Report | CO | |
| SEC Filing 8K | CO | |
| SEC Filing 8K | CO | |
| Proxy Statments | CO | |
| SEC Filing 10K | CO | |
| Slide show results | CO | |
| Annual results | CO | |
| SEC Filing 8K | CO | |
| SEC Filing 8K | CO | |
| SEC Filing 8K | CO | |
| Slide show Q3 | CO | |
| 3rd quarter results | CO | |
| SEC Filing 10Q-2 | CO | |
| SEC Filing 8K | CO | |
| SEC Filing 8K | CO | |
| SEC Filing 10Q-2 | CO | |
| 1st-half-year results | CO | |
| Slide show half-year results | CO | |
| SEC Filing 4K | CO | |
| SEC Filing 8K | CO | |
| Dividends | CO | |
| Slide show Q1 | CO | |
| 1st quarter results | CO |
- Bolsa de valores
- Acciones
- Acción BMY
- Noticias Bristol-Myers Squibb Company
- Publs. oficiales